Inventor · disambiguated record
Charles Conrad
Also filed as: CONRAD CHARLES · CONRAD CHARLES A
7 granted patents·15 pending applications·393 citations·filing 1997–2024
85Inventor score
Top patents by PatentIndex Score
22 records- 0194US6054299AStem-loop cloning vector and methodFiled 1997·Granted Apr 25, 2000·351 cites·18 claims
- 0291US10080774B2Oncolytic adenovirus armed with therapeutic genesUNIV TEXAS·Filed 2015·Granted Sep 25, 2018·10 cites·13 claims
- 0389US9061055B2Oncolytic adenovirus armed with therapeutic genesFUEYO JUAN·Filed 2009·Granted Jun 23, 2015·12 cites·10 claims
- 0482US2025171745A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2024·Application pending·0 cites
- 0573US11090344B2Adenovirus and immunomodulator combination therapyDNATRIX INC·Filed 2017·Granted Aug 17, 2021·1 cites·14 claims
- 0668US2021301264A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2021·Application pending·0 cites
- 0767US11065285B2Biomarkers and combination therapies using oncolytic virus and immunomodulationDNATRIX INC·Filed 2020·Granted Jul 20, 2021·0 cites·14 claims
- 0861US10238698B2Biomarkers and combination therapies using oncolytic virus and immunomodulationDNA TRIX INC·Filed 2013·Granted Mar 26, 2019·1 cites·6 claims
- 0960US2021213079A1Treatment of brain cancer with oncolytic adenovirusDNATRIX INC·Filed 2021·Application pending·0 cites
- 1059US6416362B1Plug adapter with safety switchFiled 2001·Granted Jul 9, 2002·18 cites·3 claims
- 1158US2016289645A1Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)DNATRIX INC·Filed 2014·Application pending·0 cites
- 1256US2019093085A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2018·Application pending·0 cites
- 1356US2006147420A1Oncolytic adenovirus armed with therapeutic genesFUEYO JUAN·Filed 2005·Application pending·0 cites
- 1452US2007292396A1Combination therapy with oncolytic adenovirusFUEYO JUAN·Filed 2007·Application pending·0 cites
- 1552US2019269744A1Biomarkers and combination therapies using oncolytic virus and immunomodulationDNATRIX INC·Filed 2019·Application pending·0 cites
- 1648US2003138405A1Conditionally replicative adenovirus to target the Rb and Rb-related pathwaysFiled 2002·Application pending·0 cites
- 1747US2016143967A1Treatment of brain cancer with oncolytic adenovirusDNATRIX INC·Filed 2014·Application pending·0 cites
- 1847US2007160581A1Production of ssDNA in vivoCYTOGENIX INC·Filed 2006·Application pending·0 cites
- 1947US2004063922A1Methods and compositions for catalytic DNA exchange in a sequence specific mannerFiled 2003·Application pending·0 cites
- 2046US2005260162A1Conditionally replicative adenovirus to target the Rb and Rb-related pathwaysFUEYO JUAN·Filed 2005·Application pending·0 cites
- 2145US2005260588A1In vivo ssdna expression vectors for altering gene expressionCONRAD CHARLES A·Filed 2003·Application pending·0 cites
- 2238US2003082800A1In vivo ssDNA expression vectors for altering gene expressionCYTOGENIX INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles Conrad files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →